HYPERION DEFI, INC. (HYPD) research

HYPERION DEFI, INC.

Sector: Healthcare
Industry: Biotechnology
Last price: $3.73
As of: 2026-10-02

HYPERION DEFI, INC. (HYPD): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-02.

As of 2026-10-02, the latest of: this ticker's 13F holdings load, its latest SEC filing date, and its latest signal other than 13F-derived signals. Source: SEC EDGAR filings for HYPD. Method and limitations.

COMPANY DOSSIER

See the full HYPD dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for HYPD on one page. Preview it with sample data, then open it live with a free account.

Preview the HYPD dossier

Active signals for HYPD

highINSTITUTIONAL_SURGE2026-08-16
CITADEL ADVISORS LLC added +231% to HYPD (2026Q2)
All 2026-08-16 signals →
mediumcorporate_crypto_treasury2026-08-12
HYPERION DEFI, INC. 8-K references ETH treasury activity · filed 2026-08-12
All 2026-08-12 signals →
mediumEARNINGS_BEAT2026-06-21
Q4-2024: Beat consensus by 5.6% - EPS $-6.93 vs $-7.344 estimate
All 2026-06-21 signals →
mediumEARNINGS_BEAT2026-06-21
Q1-2025: Beat consensus by 83.4% - EPS $-1.63 vs $-9.792 estimate
All 2026-06-21 signals →
mediumEARNINGS_BEAT2026-05-31
Beat consensus by 5.6% - EPS $-6.93 vs $-7.344 estimate
All 2026-05-31 signals →

FREE, NO ACCOUNT

Every signal on HYPD, as it fires

You are seeing 5 of 8 signals recorded on HYPD since 2026-05-31.

The five above landed across 4 days. The other 3 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in HYPD (2026Q2)

Manager / security	Market value	% portfolio	QoQ
CITADEL ADVISORS LLCCUSIP 30234E203 · 2026Q2	$177K	0.00%	,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, HYPD

8-K2026-10-02
SEC EDGAR ↗
10-Q2026-08-13
SEC EDGAR ↗
8-K2026-08-12
SEC EDGAR ↗
8-K2026-07-08
SEC EDGAR ↗
8-K2026-07-01
SEC EDGAR ↗
8-K2026-06-05
SEC EDGAR ↗
10-Q2026-05-15
SEC EDGAR ↗
8-K2026-05-14
SEC EDGAR ↗
8-K2026-05-06
SEC EDGAR ↗
10-K2026-03-30
SEC EDGAR ↗

HYPD against its peers

HYPD's operating margin of -5743.5% ranks in the 41st percentile of 10 Biotechnology sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-06-30.

Metric	HYPD	Peer median	Percentile	n
Revenue FY	813455 USD	500000 USD	54	13
Gross margin	62.7%	n/a	n/a	3
Operating margin	-5743.5%	-605.0%	41	10
Net margin	-5570.6%	-537.3%	41	10
Return on equity	-110.4%	-102.4%	48	21

Peers (23): AURX, INKT, XLO, RNTX, ACET, BOLD, MREO, ANVS, CNTB, ATHE, IBIO, GUTS, XBIT, HRTX, EXOZ, PDSB, INMB, KLRS, CSBR, SPRO, RNXT, ALDX, CING. Left out: HYFT (period gap), APLM (period gap). Fiscal periods ending between 2025-06-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (HYPD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more HYPD signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to HYPDand get the insider, 13F, options, and confluence read in one view.